Low-Dose Olanzapine Improves Appetite in Chemotherapy Patients Low-Dose Olanzapine Improves Appetite in Chemotherapy Patients
Low-dose olanzapine appears to be an effective and well-tolerated add-on intervention for the subset of patients at risk for anorexia at the start of chemotherapy, say researchers.MDedge News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
More News: Anorexia | Cancer & Oncology | Chemotherapy | Eating Disorders & Weight Management | Hematology | Zyprexa